PMC:7152526 / 177-478 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":280,"end":288},"obj":"Species"},{"id":"19","span":{"begin":180,"end":196},"obj":"Disease"},{"id":"20","span":{"begin":223,"end":231},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D001102"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":93,"end":99},"obj":"Body_part"},{"id":"T3","span":{"begin":258,"end":264},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":180,"end":196},"obj":"Disease"},{"id":"T9","span":{"begin":223,"end":231},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":45,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T3","span":{"begin":93,"end":99},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T4","span":{"begin":100,"end":103},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T5","span":{"begin":258,"end":264},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":180,"end":196},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-sentences","denotations":[{"id":"T4","span":{"begin":198,"end":274},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T6","span":{"begin":2,"end":13},"obj":"SP_7;UBERON:0001004"},{"id":"T7","span":{"begin":14,"end":36},"obj":"SP_7"},{"id":"T8","span":{"begin":93,"end":99},"obj":"UBERON:0001969"},{"id":"T9","span":{"begin":180,"end":185},"obj":"NCBITaxon:10239"},{"id":"T10","span":{"begin":223,"end":231},"obj":"SP_7"},{"id":"T11","span":{"begin":258,"end":264},"obj":"UBERON:0001969"},{"id":"T52665","span":{"begin":2,"end":13},"obj":"SP_7;UBERON:0001004"},{"id":"T91803","span":{"begin":14,"end":36},"obj":"SP_7"},{"id":"T71695","span":{"begin":93,"end":99},"obj":"UBERON:0001969"},{"id":"T89918","span":{"begin":180,"end":185},"obj":"NCBITaxon:10239"},{"id":"T68910","span":{"begin":223,"end":231},"obj":"SP_7"},{"id":"T66646","span":{"begin":258,"end":264},"obj":"UBERON:0001969"}],"text":"e respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented se"}